Another three cohort studies showed a trend of a lower risk of all-cause mortality associated with either prior use of warfarin or DOACs versus non-use of anticoagulants in patients with COVID-19 disease [ 4 , 5 , 7 ].
← all excerpts
Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study.
1
—
—